+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06970509

Improving Personalized Endoscopic and Interventional Treatments for Bleeding in Portal Hypertension Using Imaging and Clinical Models to Guide Therapy for Esophageal and Gastric Varices

Led by Shanghai Zhongshan Hospital · Updated on 2025-05-14

1450

Participants Needed

10

Research Sites

261 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are exploring new strategies to improve the treatment of esophagogastric varices in patients with cirrhosis and portal hypertension, conditions that cause dangerous bleeding. The study focuses on creating personalized treatment plans based on the unique vascular structures and blood flow patterns in each patient, aiming to reduce the high rate of rebleeding that currently occurs despite standard therapies. This observational study will help build models to better predict risks and tailor treatments for individuals. The study involves assessing patients esophagogastric varices using advanced imaging techniques like portal venous CT and ultrasound, along with clinical data, to understand their vascular characteristics. Based on this information, researchers will develop and validate models to stratify patients and guide precise treatments, including endoscopic and interventional therapies. The study will enroll multiple patient groups to train and validate these models, and also investigate whether drugs that lower portal venous pressure, such as carvedilol or new oral anticoagulants, can reduce rebleeding risk in patients with poor outcomes. Participants will undergo imaging and endoscopic examinations to collect data on their varices and overall condition. Researchers will monitor gastrointestinal bleeding and other clinical events over periods ranging from six months to five years. The study aims to evaluate the safety and effectiveness of personalized treatment approaches and assess long-term outcomes, including the potential for reversing portal hypertension. Participants may be followed up for several years to gather comprehensive data on their health status and treatment responses.

CONDITIONS

Brief Title

Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension

Research Team

Y

Yiting Wang, Ph.D.

X

xiaoquan huang, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here